Kroger’s Q3 identical sales without fuel growth faces headwinds from persistent consumer caution and softer demand trends evident in the company’s Q2 results, where the metric rose just 0.2% amid a cyclospora-related produce pullback and Inflation Reduction Act pharmacy pricing pressure. Recent investor-day commentary reaffirmed the full-year 2026 guidance range of 0.2%–0.8%, underscoring management’s view that value-focused initiatives and higher-margin e-commerce gains may only partially offset broader price sensitivity and competition from discounters. With the two leading Polymarket outcomes—1%+ at 36.5% and 0.5%–1% at 32.5%—closely matched, traders appear to weigh the potential for modest sequential improvement against risks of continued flat-to-low-single-digit performance, as industry comps across traditional grocers have steadily eroded. The December 3 earnings release will resolve the market and highlight any early effects from Kroger’s cost-simplification and private-label strategies.